Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug ...

Boston Scientific collected a set of FDA green lights for an update to its pulsed field ablation system for atrial ...

Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval ...

Medtronic received FDA approval for the Affera mapping and ablation system and Sphere-9 catheter, which can deliver both PFA ...

Boston Scientific is keeping the ball rolling in pulsed field ablation, posting 177% electrophysiology growth in the third ...

Medtronic (MDT) announced FDA approval of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one, high-density mapping ...

For instance, the acquisition of Farapulse gave Boston solid footing to compete in the evolution toward pulsed field ablation to treat atrial fibrillation. We're more wary of the recently announced ...

Boston Scientific's AVANT GUARD trial evaluates the FARAPULSE PFA System for treating persistent atrial fibrillation, pausing ...

Boston Scientific Corp. (BSX) said it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV ...

Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.

Demand for the pulsed field ablation device drove the company’s electrophysiology sales up 177% in the third quarter compared ...